• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, August 1, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Collaborative care effective for pain, depression and anxiety

Bioengineer by Bioengineer
June 29, 2021
in Health
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Provides patients with symptom-based conditions with support between physician visits

IMAGE

Credit: Regenstrief Institute

INDIANAPOLIS – With the growing prevalence of chronic pain, depression, anxiety, and other symptom-based conditions, physicians and the healthcare systems for which they work are increasingly considering how to augment the care they can provide within the limited time allotted for patient appointments.

According to Regenstrief Institute Research Scientist Kurt Kroenke, M.D., writing in the Journal of General Internal Medicine (JGIM), collaborative care can and should play a major role targeting the treatment of symptoms and functional decline, both too frequently marginalized in medically oriented care delivery.

Collaborative care is a team-based model in which the patient’s primary care physician is assisted in the management of specific health conditions (for example depression, anxiety or pain) by a care manager (often a nurse supervised by a physician specialist) with advanced expertise in the management of those conditions who provides care virtually.

Care managers help patients process information provided by their primary care physicians. For example, care managers can review treatment options, helping patients decide which option they prefer.

“We at Regenstrief and others have extensively studied utilizing collaborative care to provide behavioral treatments, education and care follow-up to patients with depression, anxiety and pain and we have found that it works,” said Dr. Kroenke, a professor of medicine at Indiana University School of Medicine, an internationally respected pioneer in symptomology and the co-developer of the depression and anxiety scales most commonly used in primary care. “Collaborative care works because it provides patients with needed support between physician visits, augmenting medical practice via telephone or another telecare modality, making it easy for patients to fit into their schedules.”

Collaborative care is becoming more common. Dr. Kroenke is currently exploring the use of collaborative care for substance abuse disorders.

“Perhaps the major reason that collaborative care hasn’t gained traction outside of some large, integrated healthcare systems with multiple clinics, is because insurance companies typically have not covered augmenting physician care via telephone,” said Dr. Kroenke. “But this barrier has eroded during the pandemic as telecare has been reimbursed by Medicare as well as insurance companies. And expanded use of telecare during the pandemic has also taught us to deliver virtual care more effectively and efficiently.”

In addition to describing the collaborative care model and highlighting its application to patient care, “Canons of Collaborative Care” by Dr. Kroenke and Andrea Cheville, M.D., of the Mayo Clinic, provides principles for implementing collaborative care in real world clinical practice.

###

About Regenstrief Institute

Founded in 1969 in Indianapolis, the?Regenstrief Institute?is a local, national and global leader dedicated to a world where better information empowers people to end disease and realize true health. A key research partner to Indiana University, Regenstrief and its research scientists are responsible for a growing number of major healthcare innovations and studies. Examples range from the development of global health information technology standards that enable the use and interoperability of electronic health records to improving patient-physician communications, to creating models of care that inform practice and improve the lives of patients around the globe.

Sam Regenstrief, a nationally successful entrepreneur from Connersville, Indiana, founded the institute with the goal of making healthcare more efficient and accessible for everyone. His vision continues to guide the institute’s research mission.

About IU School of Medicine

IU School of Medicine is the largest medical school in the U.S. and is annually ranked among the top medical schools in the nation by U.S. News & World Report. The school offers high-quality medical education, access to leading medical research and rich campus life in nine Indiana cities, including rural and urban locations consistently recognized for livability.

About Kurt Kroenke, M.D., MACP

In addition to his role as a research scientist at Regenstrief Institute, Kurt Kroenke, M.D., MACP, is also a professor of medicine at Indiana University School of Medicine.

Media Contact
Cindy Fox Aisen
[email protected]

Related Journal Article

http://dx.doi.org/10.1007/s11606-021-06929-9

Tags: Health Care Systems/ServicesMedicine/Health
Share12Tweet8Share2ShareShareShare2

Related Posts

blank

Blocking UCP2 Stops β Cell Inflammation in T2DM

August 1, 2025
Multimodal AI Predicts Thyroid Cancer Spread via Ultrasound

Multimodal AI Predicts Thyroid Cancer Spread via Ultrasound

August 1, 2025

Cancer-Associated Fibroblasts: Drivers of Drug Resistance

August 1, 2025

Technology Expert Emphasizes Continued Need for Human Touch in AI-Driven Healthcare Revolution

August 1, 2025
Please login to join discussion

POPULAR NEWS

  • Blind to the Burn

    Overlooked Dangers: Debunking Common Myths About Skin Cancer Risk in the U.S.

    60 shares
    Share 24 Tweet 15
  • Dr. Miriam Merad Honored with French Knighthood for Groundbreaking Contributions to Science and Medicine

    46 shares
    Share 18 Tweet 12
  • Study Reveals Beta-HPV Directly Causes Skin Cancer in Immunocompromised Individuals

    37 shares
    Share 15 Tweet 9
  • Sustainability Accelerator Chooses 41 Promising Projects Poised for Rapid Scale-Up

    35 shares
    Share 14 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Blocking UCP2 Stops β Cell Inflammation in T2DM

Multimodal AI Predicts Thyroid Cancer Spread via Ultrasound

Cancer-Associated Fibroblasts: Drivers of Drug Resistance

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.